Assessment of patient-reported outcomes from a randomized, DoubleBlind study of etanercept and Sulphasalazine in patients with Ankylosing spondylitis

被引：0
|
作者：
Sieper, J. [1 ]
Moots, R. [2 ]
Taylor, A. [3 ]
Sato, R. [4 ]
Singh, A. [4 ]
Robertson, D. [4 ]
Freundlich, B. [4 ]
Koenig, A. S. [4 ]
Vlahos, B. [4 ]
Ganguly, R. [4 ]
机构：
[1] Free Univ Berlin, Dept Gastroenterol & Rheumatol, D-1000 Berlin, Germany
[2] Univ Liverpool, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England
[3] Royal Perth Hosp, Dept Rheumatol, Perth, WA, Australia
[4] Wyeth Ayerst Res, Collegeville, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S580 / S581
页数：2
相关论文
共 50 条
  • [1] Significant improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept
    Singh, A.
    McHugh, N.
    Wajdula, J. S.
    Paolozzi, L.
    Zang, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 602 - 602
  • [2] Assessment of patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept for up to 160 weeks.
    Dijkmans, Benjamin A. C.
    Sieper, Joachim
    van der Linden, Sjef
    Sibilia, Jean
    Mola, Emilio Martin
    Leirisalo-Repo, Marjatta
    Pedersen, Ronald
    Singh, Amitabh
    Freundlich, Bruce
    MacPeek, David
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S725 - S725
  • [3] The effects of etanercept on patient-reported outcomes for subjects with ankylosing spondylitis.
    van der Heijde, D
    Dougados, M
    Davis, JC
    Woolley, JM
    Tsuji, W
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S174 - S175
  • [4] Improvements in patient-reported outcomes for subjects with ankylosing spondylitis receiving etanercept therapy
    Davis, JC
    Woolley, JM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 252 - 252
  • [5] Assessment of clinical efficacy in a randomized, double-blind study of etanercept and sulphasalazine in patients with ankylosing spondylitis
    Braun, J.
    Huang, F.
    Burgos-Vargas, R.
    van der Horst-Bruinsma, I. E.
    Freundlich, B.
    Vlahos, B.
    Koenig, A. S.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S415 - S415
  • [6] ASSESSMENT OF CLINICAL EFFICACY IN A RANDOMIZED, DOUBLE-BLIND STUDY OF ETANERCEPT AND SULPHASALAZINE IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    van der Horst-Bruinsma, Irene E.
    Braun, Jurgen
    Huang, Feng
    Burgos-Vargas, Ruben
    Freundlich, Bruce
    Vlahos, Bonnie
    Koenig, Andrew S.
    [J]. RHEUMATOLOGY, 2009, 48 : I54 - I54
  • [7] Five-year efficacy and safety, including patient-reported outcomes, with etanercept in ankylosing spondylitis
    Mola, E. Martin
    van der Linden, S.
    Wishneski, C.
    Robertson, D.
    Freundlich, B. F.
    Koenig, A. S.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S584 - S585
  • [8] Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis
    Martin-Mola, E.
    Sieper, J.
    Leirisalo-Repo, M.
    Dijkmans, B. A. C.
    Vlahos, B.
    Pedersen, R.
    Koenig, A. S.
    Freundlich, B.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 238 - 245
  • [9] Association of Healthcare Utilization and Costs with Patient-Reported Outcomes in Patients with Ankylosing Spondylitis
    Ogdie, Alexis
    Hwang, Mark
    Veeranki, Phani
    Portelli, Alexandria
    Sison, Steven
    Shafrin, Jason
    Pedro, Sofia
    Yi, Esther
    Michaud, Kaleb
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] Norms-based assessment of patient-reported outcomes associated with adalimumab monotherapy in patients with ankylosing spondylitis
    Kimel, M.
    Revicki, D.
    Rao, S.
    Fryback, D.
    Feeny, D.
    Harnam, N.
    Thompson, C.
    Cifaldi, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 624 - 632
12345